STAT

The Senate could soon pass an opioids package. But a new law is still a long way away

The House passed a big opioids bill, the Senate is about to vote on its own version — but a law? That’s a long way off.
A man walks by a billboard for a drug recovery center in Youngstown, Ohio.

WASHINGTON — The Senate is likely to pass a comprehensive bill to address the opioid crisis in the coming weeks. The House did so in June.

But the finish line on that long-discussed priority remains a long way off.

Lawmakers have left untouched many of the bill’s most contentious issues, like debates over patient privacy and expensive changes to Medicaid payments for addiction treatment. There’s no sign yet they’ll iron out those issues before the Senate votes.

That procrastination means a select group of lawmakers will spend September and October — if not longer — hammering out the contentious details. A final vote, lawmakers, congressional aides, and

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks